Dermatitis and Eczema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Infants diagnosed with atopic dermatitis who are between 1 and 4 years old at the time of consent acquisition. 2) The research participant whose parent or guardian has received sufficient explanation of the research, understands its contents, and can provide written consent.
Exclusion criteria
Exclusion criteria: Those who use topical steroids classified as strongyles (group I) or belly-strength (group II) as described in the "Atopic Dermatitis Clinical Practice Guidelines 2018 2) Those who have taken drugs (antibiotics) that affect the intestinal environment for one month prior to the start of the test food intake or will take them during the test. 3) Those who have a history of or are currently suffering from serious diseases of the heart, liver, kidneys, digestive organs, etc. 4) Those who are allergic to kestose or maltose. 5) Those who are currently participating in a clinical trial of another drug or health food, or who plan to participate in another clinical trial within 4 weeks after the completion of the trial, or after consenting to participate in the trial. 6) Those who are judged inappropriate to participate in the study by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intestinal microbiota and intestinal metabolites. | — |
Secondary
| Measure | Time frame |
|---|---|
| Saliva IgA content, stool IgA content, defecation status, POEM score and SCOR score | — |
Contacts
Nihonkai General Hospital